Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/4305
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRakhimova M.E., Muzaffarov J.Sh..-
dc.date.accessioned2026-06-11T15:26:09Z-
dc.date.available2026-06-11T15:26:09Z-
dc.date.issued2025-05-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/4305-
dc.description.abstractDiagnosis and treatment of chronic coronary heart disease (CHD) is well developed, but there are often difficulties in managing patients with comorbid diseases. A very common chronic kidney disease (CKD) occupies a special place among comorbidities. The cause of death in patients with kidney dysfunction is significantly more often CHD than end-stage renal disease (ESRD). In recent years, cystatin C has been considered as an early marker for assessing the functional state of the kidneys and cardiovascular risk, the level of which, unlike creatinine, does not depend on gender, age, race, and muscle mass.en_US
dc.language.isoen_USen_US
dc.publisherCentral Asian Research Journal for Interdisciplinary Studiesen_US
dc.relation.ispartofseriesУДК:;616.61-008.6-07:616.12-
dc.subjectcoronary heart disease, cystatin C, functional state of the kidneys.en_US
dc.titleTHE ROLE OF CYSTATIN C IN ASSESSING THE FUNCTIONAL STATE OF THE KIDNEYS IN PA TIENTS WITH CORONARY HEART DISEASEen_US
dc.typeArticleen_US
Appears in Collections:

Files in This Item:
File Description SizeFormat 
6. THE ROLE OF CYSTATIN C IN ASSESSING THE.pdf1.09 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.